CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-03 | Stilley William B. III Chief Executive Officer | Grant or award | +54,167 | 690,937 | ||
| 2020-03-03 | Stilley William B. III Chief Executive Officer | Grant or award · Stock Option | +460,000 | 460,000 | ||
| 2020-03-03 | Truluck Joseph Chief Financial Officer | Grant or award | +27,084 | 107,639 | ||
| 2020-03-03 | Truluck Joseph Chief Financial Officer | Grant or award · Employee Stock Option | +20,000 | 200,000 | ||
| 2020-03-03 | Newman James W. Jr. Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2020-03-03 | Goodman Tony Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2020-03-03 | Anderson J. Kermit Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2019-12-12 | Johnson Bankole A. Chief Medical Officer | Sale | −150,000 | $1.00 | $150K | 698,336 |
| 2019-10-02 | Johnson Bankole A. Chief Medical Officer | Grant or award | +3,187 | 351,055 | ||
| 2019-03-29 | Johnson Bankole A. Chief Medical Officer | Purchase | +30,000 | $3.47 | $104K | 344,768 |
| 2019-03-29 | Johnson Bankole A. Chief Medical Officer | Purchase | +2,500 | $3.47 | $9K | 347,268 |
| 2019-03-29 | Johnson Bankole A. Chief Medical Officer | Purchase | +600 | $3.30 | $2K | 347,868 |
| 2019-03-28 | Johnson Bankole A. Chief Medical Officer | Purchase | +40,000 | $3.15 | $126K | 314,768 |
| 2019-03-24 | Johnson Bankole A. Chief Medical Officer | Grant or award · Stock Option | +250,000 | 250,000 | ||
| 2019-03-10 | Truluck Joseph Chief Financial Officer | Grant or award · Stock Option | +180,000 | 180,000 | ||
| 2019-03-10 | Stilley William B. III Chief Executive Officer | Grant or award · Stock Option | +500,000 | 500,000 | ||
| 2018-11-12 | Schuyler Kevin Director | Other disposition · Warrant to purchase units | −89,600 | 0 | ||
| 2018-11-12 | Schuyler Kevin Director | Other acquisition · Warrant to purchase common stock | +89,600 | 89,600 | ||
| 2018-11-12 | Schuyler Kevin Director | Other acquisition · Warrant to purchase common stock | +89,600 | 89,600 | ||
| 2018-11-12 | Schuyler Kevin Director | Other disposition · Warrant to purchase units | −192,600 | 0 |
Page 7 of 10 · 190 trades